23.60
+0.49
+(2.12%)
At close: April 16 at 4:00:00 PM EDT
21.86
-1.74
(-7.37%)
Pre-Market: 9:14:32 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
FOEHR MATTHEW W Director | Conversion of Exercise of derivative security | Apr 11, 2025 | 132,036 |
LIAN BRIAN Chief Executive Officer | Sale | Jan 6, 2025 | 2,366,570 |
LIGAND PHARMACEUTICALS, INC. Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 26, 2020 | 5,819,380 |
MACARTNEY LAWSON Director | Sale | Nov 8, 2024 | 47,965 |
MANCINI MARIANNA Chief Operating Officer | Sale | Jan 6, 2025 | 374,134 |
MORNEAU MICHAEL Officer | Stock Award(Grant) | Jan 4, 2021 | 117,747 |
ROUAN SARAH KATHRYN Director | Purchase | Mar 31, 2025 | 1,240 |
ROWLAND CHARLES A JR Director | Sale | May 16, 2023 | 30,000 |
SINGLETON J MATTHEW Director | Sale | Oct 25, 2024 | 9,500 |
ZANTE GREGORY S Chief Financial Officer | Sale | Jan 6, 2025 | 165,259 |
Related Tickers
SMMT Summit Therapeutics Inc.
23.05
-6.38%
CRSP CRISPR Therapeutics AG
37.78
-3.00%
RXRX Recursion Pharmaceuticals, Inc.
5.32
-5.67%
VERV Verve Therapeutics, Inc.
4.5100
-9.26%
GPCR Structure Therapeutics Inc.
18.53
-1.96%
MURA Mural Oncology plc
2.4200
+0.41%
NVAX Novavax, Inc.
6.20
-2.97%
IOVA Iovance Biotherapeutics, Inc.
3.0700
-4.95%
PRTG Portage Biotech Inc.
6.75
-15.52%
MDGL Madrigal Pharmaceuticals, Inc.
307.78
-4.15%